Cutera stock had its Relative Strength (RS) Rating upgraded from 80 to 90 Monday.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. This proprietary rating tracks market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the trailing 52 weeks matches up against other publicly traded companies.
History reveals that the best-performing stocks typically have an RS Rating of at least 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Cutera Stock A Buy?
Cutera stock is building a consolidation with a 54.14 buy point. See if it can clear the breakout price in volume at least 40% higher than normal. Keep in mind that it's a later-stage consolidation, and those are riskier than earlier-stage patterns.
The medical aesthetic company posted -180% earnings growth in its most recent report, while sales growth came in at 10%.
Cutera stock earns the No. 19 rank among its peers in the Medical-Systems/Equipment industry group. Sensus Healthcare, Shockwave Medical and Haemonetics are among the top 5 highly rated stocks within the group.
